On March 18, 2015 the Canadian Intellectual Property Office (“CIPO”) issued a Patent Notice: Revised Examination Practice Respecting Medical Uses (the “Notice”).
March 31, 2015
On 26 February 2015, the UK Government published its response to the Law Commission’s proposed reforms to the groundless threats of intellectual property right infri
March 27, 2015
On March 16, 2015, Justice Barnes of the Federal Court issued his decision in AstraZeneca Canada Inc. et al v. Apotex Inc., 2015 FC 322.
March 24, 2015
South Africa remains the international gateway to the rest of Africa and the ports of Durban, Richards Bay and Saldanha Bay remain the busiest on the continent.
March 19, 2015
This case is the most recent in a small line of cases concerning the intellectual property implications, or lack thereof.
March 11, 2015
On February 12, 2015, Quebec’s Minister of Health and Social Services announced new rules regarding the use of the instruction “do not substitute”.
March 02, 2015
Janssen Inc (Janssen) brought two Applications pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations.
In a highly anticipated ruling, on 15 January 2015, the CJEU held in a preliminary reference made to it in Ryanair Limited v PR Aviation BV that databases which are
February 16, 2015
Janssen appealed from the decision of Justice Barnes of the Federal Court refusing to prohibit the Minister of Health from issuing a Notice of Compliance to Teva.
February 10, 2015
On January 23, 2015, the Federal Court released its public reasons for Judgment granting Eli Lilly and Company and Eli Lilly Canada patent infringement damages.
January 30, 2015
Try searching our global site instead